Skip to main content

Find Clinical Trials

Home
Conditions
Lung Diseases, Obstructive

Clinical trial condition

Lung Diseases, Obstructive

Explore clinical trials studying Lung Diseases, Obstructive. Study availability and eligibility vary by location and protocol.

7,958 public trials 738 recruiting studies

Refine in advanced search Browse all conditions

Lung Diseases, Obstructive trial results

Completed

Spiriva® Assessment of FEV1 (SAFE)

NCT00277264

Conditions: Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations: Respiratory Research, Room 1742 Calgary, Alberta, Canada

Boehringer Ingelheim Investigational Site Calgary, Alberta, Canada

4A-185, 7007-14 Street SW Calgary, Alberta, Canada

Boehringer Ingelheim Investigational Site Edmonton, Alberta, Canada

View all 96 locations

View Trial Details

Completed

Center for Reducing Asthma Disparities - Rhode Island/Puerto Rico Centers

NCT00281138

Conditions: Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations: Not specified

View Trial Details

Completed

Efficacy and Safety of Tiotropium Inhalation Capsules and Atrovent MDI in Patients With Chronic Obstructive Pulmonary Disease (COPD)

NCT00274092

Conditions: Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations: Kaohsiung Veterans General Hospital Kaohsiung City, Taiwan

Kaohsiung Medical University Chung-Ho Memorial Hospital Kaohsiung City, Taiwan

Veterans General Hospital Taichung, Taiwan

National Taiwan University Hospital Taipei, Taiwan

View Trial Details

Completed

A Comparison of the Effects of Tiotropium Inhalation qd and Salmeterol Inhalation Bid on Arterial Blood Gases.

NCT00274534

Conditions: Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations: Hines Veterans Administration Hospital Hines, Illinois, United States

Hunter Holmes McGuire Medical Center Richmond, Virginia, United States

View Trial Details

Completed

A Randomised, Double-blind, Placebo-controlled, 12 Week Trial to Evaluate the Effect of Tiotropium Inhalation Capsules (Spiriva) on the Magnitude of Exercise, Measured Using an Accelerometer, in Patients With Chronic Obstructive Pulmonary Disease (COPD)

NCT00144326

Conditions: Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations: 1796 Summer Street Halifax, Nova Scotia, Canada

Kingston General Hospital Kingston, Ontario, Canada

Respiratory/ Research Lab Toronto, Ontario, Canada

Montreal Chest Institute of the Royal Victoria Hospital Montreal, Quebec, Canada

View all 27 locations

View Trial Details

Completed

12 Week Comparison of 5 Mcg and 10 Mcg of Tiotropium / Respimat, Placebo and Ipratropium MDI in COPD

NCT00239473

Conditions: Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations: Boehringer Ingelheim Investigational Site Berlin, Germany

MEDARS GmbH Berlin, Germany

Boehringer Ingelheim Investigational Site Bonn, Germany

Boehringer Ingelheim Investigational Site Frankfurt am Main, Germany

View all 38 locations

View Trial Details

Completed

Efficacy and Safety Comparison of Tiotropium Inhalation Solution (Respimat Inhaler) and Spiriva HandiHaler in Chronic Obstructive Pulmonary Disease (COPD)

NCT00281567

Conditions: Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations: Boehringer Ingelheim Investigational Site Study Chairs Or Principal Investigators, Belgium

Boehringer Ingelheim Investigational Site Study Chairs Or Principal Investigators, Netherlands

View Trial Details

Completed

A Six-week Study Comparing the Efficacy and Safety of Tiotropium Plus Formoterol to Salmeterol Plus Fluticasone in Chronic Obstructive Pulmonary Disease (COPD)

NCT00239421

Conditions: Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations: Med. Uni.-Klinik Graz Graz, Austria

Boehringer Ingelheim Investigational Site Vienna, Austria

Klinikum Kreuzschwestern Wels Wels, Austria

Sint-Vincentius Ziekenhuis Antwerp, Belgium

View all 56 locations

View Trial Details

Completed

Multiple Rising Dose Study of BI 144807 Powder in Bottle in Mild Asthmatic Patients

NCT01651598

Conditions: Asthma, Bronchial Diseases, Healthy, +7 more
Locations: 1313.2.44001 Boehringer Ingelheim Investigational Site Manchester, United Kingdom

View Trial Details

Completed

SPIRIVA in Ususal Care

NCT00274079

Conditions: Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations: Foresterhill Healthcentre Aberdeen, United Kingdom

Boehringer Ingelheim Investigational Site Airdrie, United Kingdom

Boehringer Ingelheim Investigational Site Atherstone, United Kingdom

Boehringer Ingelheim Investigational Site Barry, United Kingdom

View all 44 locations

View Trial Details